$LTRN
Lantern Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.898
▼-5.87%-$0.056
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLantern Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LTRN down today? It is at $0.898 (-5.87%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LTRN spikes, and full due diligence on LTRN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LTRN 16 times in the last 30 days. Create a free account to track $LTRN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LTRN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LTRN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Across every filing on file, supply equal to 75.4% of the tradeable float is in play - 75.4% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
7,339,450 new shares · Priced at $1.09/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Keyser D Jeffrey Director | Bought (open market) | +49K 0.4% of company | added 100% | 94K | $100K at $2.06 | May 12, 26 |
Schalop Lee Troy Director | Bought (open market) | +49K 0.4% of company | n/a | 49K | $100K at $2.06 | May 12, 26 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -40K 0.3% of company | sold 3.6% | 1.08M | $124K at $3.09 | Jun 13, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -40K 0.3% of company | sold 3.6% | 1.08M | $124K at $3.09 | Jun 13, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.5% of company | sold 5.2% | 1.12M | $205K at $3.38 | Jun 12, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.5% of company | sold 5.2% | 1.12M | $205K at $3.38 | Jun 12, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -950 | sold 1.7% | 55K | $3K at $3.40 | Jun 11, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -950 | sold 1.7% | 55K | $3K at $3.40 | Jun 11, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -16 | sold <0.1% | 55K | $54 at $3.40 | Jun 10, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -16 | sold <0.1% | 55K | $54 at $3.40 | Jun 10, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -20K 0.2% of company | sold 1.7% | 1.18M | $61K at $3.03 | May 29, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -20K 0.2% of company | sold 1.7% | 1.18M | $61K at $3.03 | May 29, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LTRN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LTRN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LTRN last traded at $0.898, down 5.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lantern Pharma Inc. Common Stock (LTRN) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LTRN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LTRN 16 times in the last 30 days.
LTRN (Lantern Pharma Inc. Common Stock) trades on XNAS, with a market cap of about $12M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LTRN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LTRN discussion
Sign in to ask a question or join the discussion.